These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3654616)

  • 21. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
    Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL
    Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III.
    Griffith MJ; Noyes CM; Church FC
    J Biol Chem; 1985 Feb; 260(4):2218-25. PubMed ID: 3838304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptic peptide mapping of sequence 1-298 of human serum albumin by high-performance liquid chromatography and fast-atom bombardment mass spectrometry.
    Compagnini A; Fisichella S; Foti S; Saletti R; Sardo L
    Rapid Commun Mass Spectrom; 1994 Jun; 8(6):459-64. PubMed ID: 8043915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation and stability of the complex formed between human antithrombin-III and thrombin.
    Ferguson WS; Finlay TH
    Arch Biochem Biophys; 1983 Jan; 220(1):301-8. PubMed ID: 6338832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.
    Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST
    J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
    Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
    Kress LF; Catanese J
    Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of human factor XIIa by plasma proteinase inhibitors.
    Pixley RA; Schapira M; Colman RW
    J Biol Chem; 1985 Feb; 260(3):1723-9. PubMed ID: 2578463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.
    Koide T; Takahashi K; Odani S; Ono T; Sakuragawa N
    Thromb Res; 1983 Jul; 31(2):319-28. PubMed ID: 6636046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin.
    Lindo VS; Kakkar VV; Learmonth M; Melissari E; Zappacosta F; Panico M; Morris HR
    Br J Haematol; 1995 Mar; 89(3):589-601. PubMed ID: 7734359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of thrombin-antithrombin III complex with vitronectin in serum.
    Ill CR; Ruoslahti E
    J Biol Chem; 1985 Dec; 260(29):15610-5. PubMed ID: 2415521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His.
    Owen MC; Borg JY; Soria C; Soria J; Caen J; Carrell RW
    Blood; 1987 May; 69(5):1275-9. PubMed ID: 3567355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A heparin binding site in antithrombin III. Identification, purification, and amino acid sequence.
    Smith JW; Knauer DJ
    J Biol Chem; 1987 Sep; 262(25):11964-72. PubMed ID: 3305499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression in a cell-free system of normal and variant forms of human antithrombin III. Ability to bind heparin and react with alpha-thrombin.
    Austin RC; Rachubinski RA; Fernandez-Rachubinski F; Blajchman MA
    Blood; 1990 Oct; 76(8):1521-9. PubMed ID: 2207328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)].
    Aiach M; Fiessinger JN; Andreux JP; Beuvin J; Housset E; Leclerc M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():35-41. PubMed ID: 353657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation and dissociation of the covalent complexes between trypsin and two homologous inhibitors, alpha 1-antitrypsin and antithrombin III.
    Mahoney WC; Kurachi K; Hermodson MA
    Eur J Biochem; 1980 Apr; 105(3):545-52. PubMed ID: 6966218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of recombinant DNA derived human relaxin to probe the structure of the native protein.
    Canova-Davis E; Kessler TJ; Lee PJ; Fei DT; Griffin P; Stults JT; Wade JD; Rinderknecht E
    Biochemistry; 1991 Jun; 30(24):6006-13. PubMed ID: 2043638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding.
    Peterson CB; Blackburn MN
    J Biol Chem; 1985 Jan; 260(1):610-5. PubMed ID: 3965464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Location of disulfide bonds in antithrombin III.
    Zhou ZR; Smith DL
    Biomed Environ Mass Spectrom; 1990 Dec; 19(12):782-6. PubMed ID: 2088576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.